{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:10:22Z","timestamp":1795209022222,"version":"4.10.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2303401"],"award-info":[{"award-number":["2022YFC2303401"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2604101"],"award-info":[{"award-number":["2022YFC2604101"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2304100"],"award-info":[{"award-number":["2022YFC2304100"]}]},{"name":"Natural Science Foundation of Beijing","award":["No.M23014"],"award-info":[{"award-number":["No.M23014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Since the COVID-19 pandemic, there has been a documented rise in the incidence of neurological manifestations among individuals complicated with encephalitis or myelitis. The spectrum of neurological symptoms associated with HCoVs infections is expanding. However, the infection characteristics and pathogenesis of seasonal HCoVs to the central nervous system remain obscure. No pharmacological agents have demonstrated the capacity to specifically and efficaciously mitigate the neurological symptoms induced by HCoVs infections to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed human cerebral organoids (HCOs) derived from human induced pluripotent stem cells and established a blood\u2013brain barrier (BBB) HCOs co-culture model. We subjected these models to seasonal human coronavirus (HCoV) infections to investigate the viral characteristics within the central nervous system (CNS). Utilizing RNA sequencing, we conducted a preliminary exploration of the mechanisms underlying virus-induced inflammatory responses in the CNS. Furthermore, we assessed the efficacy of antiviral and anti-inflammatory drugs using the HCO model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results showed that among seasonal coronaviruses, HCoV-OC43 replicates efficiently within the organoids, primarily targeting neurons and astrocytes, and disrupts the barrier function of the BBB. RNA sequencing analysis revealed that HCoV-OC43 infection triggers an inflammatory response through the TNF and NF-\u03baB signaling pathways, leading to cell death, impaired neuronal function, and disrupted interneuron signaling. Interestingly, Bardoxolone methyl (CDDO-Me) demonstrated antiviral effects comparable to remdesivir, reducing both inflammation and cell death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Conclusively, HCOs infected with HCoV-OC43 offer valuable insights into the pathogenesis of HCoVs in central nervous system (CNS), and might serve as a tool for developing novel therapeutic strategies for HCoVs infections, including COVID-19, especially on exploring treatment candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-025-01193-z","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:02:20Z","timestamp":1762358540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human coronavirus OC43 infection in human cerebral organoids: novel insights on pathogenesis and potential therapeutic interventions"],"prefix":"10.1186","volume":"32","author":[{"given":"Juntong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roujian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/acn3.51166","volume":"7","author":"J Almqvist","year":"2020","unstructured":"Almqvist J, Granberg T, Tzortzakakis A, Klironomos S, Kollia E, \u00d6hberg C, et al. Neurological manifestations of coronavirus infections - a systematic review. Ann Clin Transl Neurol. 2020;7:2057\u201371.","journal-title":"Ann Clin Transl Neurol"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1111\/ene.15045","volume":"28","author":"G Cosentino","year":"2021","unstructured":"Cosentino G, Todisco M, Hota N, Della Porta G, Morbini P, Tassorelli C, et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28:3856\u201365.","journal-title":"Eur J Neurol"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0042-6822(92)90220-J","volume":"191","author":"JN Stewart","year":"1992","unstructured":"Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992;191:502\u20135.","journal-title":"Virology"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758\u201363.","journal-title":"Nature"},{"key":"1193_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18052621","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18052621.","journal-title":"Int J Environ Res Public Health"},{"key":"1193_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/v13010132","author":"P Kumari","year":"2021","unstructured":"Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, et al. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13010132.","journal-title":"Viruses"},{"issue":"5","key":"1193_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111573","volume":"41","author":"D Beckman","year":"2022","unstructured":"Beckman D, Bonillas A, Diniz GB, Ott S, Roh JW, Elizaldi SR, et al. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022;41(5):111573.","journal-title":"Cell Rep"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s13365-020-00926-0","volume":"27","author":"MC Kasereka","year":"2021","unstructured":"Kasereka MC, Hawkes MT. Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host. J Neurovirol. 2021;27:340\u20134.","journal-title":"J Neurovirol"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/23744235.2020.1729403","volume":"52","author":"A Nilsson","year":"2020","unstructured":"Nilsson A, Edner N, Albert J, Ternhag A. Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Infect Dis. 2020;52:419\u201322.","journal-title":"Infect Dis"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pediatrneurol.2021.01.007","volume":"117","author":"TG Singer","year":"2021","unstructured":"Singer TG, Evankovich KD, Fisher K, Demmler-Harrison GJ, Risen SR. Coronavirus infections in the nervous system of children: a scoping review making the case for long-term neurodevelopmental surveillance. Pediatr Neurol. 2021;117:47\u201363.","journal-title":"Pediatr Neurol"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.33588\/rn.7009.2020179","volume":"70","author":"FJ Carod-Artal","year":"2020","unstructured":"Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70:311\u201322. https:\/\/doi.org\/10.33588\/rn.7009.2020179","journal-title":"Rev Neurol"},{"key":"1193_CR12","volume":"113","author":"EA Yeh","year":"2004","unstructured":"Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113:e73\u20136.","journal-title":"Pediatrics"},{"key":"1193_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70314","volume":"97","author":"J Fourgeaud","year":"2025","unstructured":"Fourgeaud J, Turlure P, Dupont M, Veyrenche N, Busquet C, Alain S, et al. Remdesivir for the treatment of human coronavirus OC43 encephalitis. J Med Virol. 2025;97:e70314. https:\/\/doi.org\/10.1002\/jmv.70314.","journal-title":"J Med Virol"},{"issue":"19","key":"1193_CR14","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1128\/jvi.74.19.8913-8921.2000","volume":"74","author":"N Arbour","year":"2000","unstructured":"Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913\u201321. https:\/\/doi.org\/10.1128\/jvi.74.19.8913-8921.2000.","journal-title":"J Virol"},{"issue":"3","key":"1193_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/wnl.32.3.292","volume":"32","author":"A Salmi","year":"1982","unstructured":"Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology. 1982;32(3):292\u20135. https:\/\/doi.org\/10.1212\/wnl.32.3.292. (PMID: 6278362).","journal-title":"Neurology"},{"issue":"2","key":"1193_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.870070210","volume":"7","author":"E Fazzini","year":"1992","unstructured":"Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson\u2019s disease. Mov Disord. 1992;7(2):153\u20138. https:\/\/doi.org\/10.1002\/mds.870070210.","journal-title":"Mov Disord"},{"issue":"3","key":"1193_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70314","volume":"97","author":"J Fourgeaud","year":"2025","unstructured":"Fourgeaud J, Turlure P, Dupont M, Veyrenche N, Busquet C, Alain S, et al. Remdesivir for the treatment of human coronavirus OC43 encephalitis. J Med Virol. 2025;97(3):e70314. https:\/\/doi.org\/10.1002\/jmv.70314.","journal-title":"J Med Virol"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1128\/JVI.73.4.3338-3350.1999","volume":"73","author":"N Arbour","year":"1999","unstructured":"Arbour N, C\u00f4t\u00e9 G, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol. 1999;73:3338\u201350.","journal-title":"J Virol"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1128\/jvi.71.1.800-806.1997","volume":"71","author":"A Bonavia","year":"1997","unstructured":"Bonavia A, Arbour N, Yong VW, Talbot PJ. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J Virol. 1997;71:800\u20136.","journal-title":"J Virol"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1128\/JVI.73.4.3326-3337.1999","volume":"73","author":"N Arbour","year":"1999","unstructured":"Arbour N, Ekand\u00e9 S, C\u00f4t\u00e9 G, Lachance C, Chagnon F, Tardieu M, et al. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol. 1999;73:3326\u201337.","journal-title":"J Virol"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/13550284.2010.497806","volume":"16","author":"H Jacomy","year":"2010","unstructured":"Jacomy H, St-Jean JR, Brison E, Marceau G, Desforges M, Talbot PJ. Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB\/c mice from encephalitis to flaccid paralysis and demyelination. J Neurovirol. 2010;16:279\u201393.","journal-title":"J Neurovirol"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/978-0-387-33012-9_96","volume":"581","author":"N Butler","year":"2006","unstructured":"Butler N, Pewe L, Trandem K, Perlman S. HCoV-OC43-induced encephalitis is in part immune-mediated. Adv Exp Med Biol. 2006;581:531\u20134.","journal-title":"Adv Exp Med Biol"},{"key":"1193_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.virol.2006.01.049","volume":"349","author":"H Jacomy","year":"2006","unstructured":"Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB\/C mice. Virology. 2006;349:335\u201346.","journal-title":"Virology"},{"key":"1193_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature25032","volume":"553","author":"SP Pa\u0219ca","year":"2018","unstructured":"Pa\u0219ca SP. The rise of three-dimensional human brain cultures. Nature. 2018;553:437\u201345.","journal-title":"Nature"},{"key":"1193_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.stem.2020.09.016","volume":"27","author":"F Jacob","year":"2020","unstructured":"Jacob F, Pather SR, Huang W-K, Zhang F, Wong SZH, Zhou H, et al. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell. 2020;27:937-950.e9.","journal-title":"Cell Stem Cell"},{"key":"1193_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/v10120693","author":"MJ Reddehase","year":"2018","unstructured":"Reddehase MJ, Lemmermann NAW. Mouse model of cytomegalovirus disease and immunotherapy in the immunocompromised host: predictions for medical translation that survived the \u201cTest of Time.\u201d Viruses. 2018. https:\/\/doi.org\/10.3390\/v10120693.","journal-title":"Viruses"},{"key":"1193_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin C-A, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373\u20139.","journal-title":"Nature"},{"issue":"5","key":"1193_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hlife.2024.09.003","volume":"3","author":"J Liu","year":"2024","unstructured":"Liu J, Zhu N, Huo W, Tan W. Advancing virology research with a human brain organoid platform. hLife. 2024;3(5):237\u201342.","journal-title":"hLife."},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell. 2016;165:1238\u201354.","journal-title":"Cell"},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.stem.2021.03.004","volume":"28","author":"V Krenn","year":"2021","unstructured":"Krenn V, Bosone C, Burkard TR, Spanier J, Kalinke U, Calistri A, et al. Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly. Cell Stem Cell. 2021;28:1362-1379.e7.","journal-title":"Cell Stem Cell"},{"key":"1193_CR31","doi-asserted-by":"publisher","first-page":"230822","DOI":"10.1128\/mbio.02308-22","volume":"13","author":"W Kong","year":"2022","unstructured":"Kong W, Montano M, Corley MJ, Helmy E, Kobayashi H, Kinisu M, et al. Neuropilin-1 mediates SARS-CoV-2 infection of astrocytes in brain organoids, inducing inflammation leading to dysfunction and death of neurons. MBio. 2022;13:230822.","journal-title":"MBio"},{"key":"1193_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41419-018-0763-y","volume":"9","author":"B Zhang","year":"2018","unstructured":"Zhang B, He Y, Xu Y, Mo F, Mi T, Shen QS, et al. Differential antiviral immunity to Japanese encephalitis virus in developing cortical organoids. Cell Death Dis. 2018;9:719.","journal-title":"Cell Death Dis"},{"key":"1193_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp596","volume":"37","author":"D Parkhomchuk","year":"2009","unstructured":"Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L, Krobitsch S, et al. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res. 2009;37:e123.","journal-title":"Nucleic Acids Res"},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27:29\u201334.","journal-title":"Nucleic Acids Res"},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fncel.2019.00230","volume":"13","author":"NL Stone","year":"2019","unstructured":"Stone NL, England TJ, O\u2019Sullivan SE. A novel transwell blood brain barrier model using primary human cells. Front Cell Neurosci. 2019;13:230.","journal-title":"Front Cell Neurosci"},{"key":"1193_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.1067","volume":"4","author":"JR Malik","year":"2024","unstructured":"Malik JR, Modebelu UO, Fletcher CV, Podany AT, Scarsi KK, Byrareddy SN, et al. Establishment of a four-cell in vitro blood-brain barrier model with human primary brain cells. Curr Protoc. 2024;4:e1067.","journal-title":"Curr Protoc"},{"key":"1193_CR38","doi-asserted-by":"publisher","first-page":"9.58.1","DOI":"10.1002\/cpns.25","volume":"79","author":"R Natarajan","year":"2017","unstructured":"Natarajan R, Northrop N, Yamamoto B. Fluorescein isothiocyanate (FITC)-dextran extravasation as a measure of blood-brain barrier permeability. Curr Protoc Neurosci. 2017;79:9.58.1-9.58.15.","journal-title":"Curr Protoc Neurosci"},{"key":"1193_CR39","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106230","volume":"39","author":"A Ramani","year":"2020","unstructured":"Ramani A, M\u00fcller L, Ostermann PN, Gabriel E, Abida-Islam P, M\u00fcller-Schiffmann A, et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230.","journal-title":"EMBO J"},{"key":"1193_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/v12091004","author":"SA Yi","year":"2020","unstructured":"Yi SA, Nam KH, Yun J, Gim D, Joe D, Kim YH, et al. Infection of brain organoids and 2D cortical neurons with SARS-CoV-2 pseudovirus. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12091004.","journal-title":"Viruses"},{"key":"1193_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41422-020-0390-x","volume":"30","author":"B-Z Zhang","year":"2020","unstructured":"Zhang B-Z, Chu H, Han S, Shuai H, Deng J, Hu Y-F, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928\u201331.","journal-title":"Cell Res"},{"key":"1193_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-022-00723-9","volume":"18","author":"OL Eichm\u00fcller","year":"2022","unstructured":"Eichm\u00fcller OL, Knoblich JA. Human cerebral organoids - a new tool for clinical neurology research. Nat Rev Neurol. 2022;18:661\u201380.","journal-title":"Nat Rev Neurol"},{"key":"1193_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe \u00c5, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107\u201313.","journal-title":"Nature"},{"key":"1193_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100905","volume":"42","author":"C LaCourse","year":"2024","unstructured":"LaCourse C. Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19. Brain Behav Immun Health. 2024;42:100905.","journal-title":"Brain Behav Immun Health"},{"key":"1193_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/v15020578","author":"IlM Kim","year":"2023","unstructured":"Kim IlM, Lee C. Human coronavirus OC43 as a low-risk model to study COVID-19. Viruses. 2023. https:\/\/doi.org\/10.3390\/v15020578.","journal-title":"Viruses"},{"key":"1193_CR46","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","volume":"41","author":"J Hicks","year":"2021","unstructured":"Hicks J, Klumpp-Thomas C, Kalish H, Shunmugavel A, Mehalko J, Denson J-P, et al. Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses. J Clin Immunol. 2021;41:906\u201313.","journal-title":"J Clin Immunol"},{"key":"1193_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00404-18","author":"M Dub\u00e9","year":"2018","unstructured":"Dub\u00e9 M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018. https:\/\/doi.org\/10.1128\/JVI.00404-18.","journal-title":"J Virol"},{"key":"1193_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167280","volume":"434","author":"MM Rajah","year":"2022","unstructured":"Rajah MM, Bernier A, Buchrieser J, Schwartz O. The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation. J Mol Biol. 2022;434:167280.","journal-title":"J Mol Biol"},{"key":"1193_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijid.2020.09.1429","volume":"101","author":"DL Wannigama","year":"2020","unstructured":"Wannigama DL, Jacquet A. NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS-CoV2? Int J Infect Dis. 2020;101:52\u20135.","journal-title":"Int J Infect Dis"},{"key":"1193_CR50","first-page":"2075","volume":"8","author":"Y-Y Wang","year":"2014","unstructured":"Wang Y-Y, Yang Y-X, Zhe H, He Z-X, Zhou S-F. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug Des Devel Ther. 2014;8:2075\u201388.","journal-title":"Drug Des Devel Ther"},{"key":"1193_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12985-023-02213-w","volume":"20","author":"YL Chi","year":"2023","unstructured":"Chi YL, Xie Y, Liu SQ, Zhu WY. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro. Virol J. 2023;20:258.","journal-title":"Virol J"},{"key":"1193_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011506","volume":"19","author":"FH Waqas","year":"2023","unstructured":"Waqas FH, Shehata M, Elgaher WAM, Lacour A, Kurmasheva N, Begnini F, et al. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathog. 2023;19:e1011506.","journal-title":"PLoS Pathog"},{"key":"1193_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-021-00628-x","volume":"6","author":"Q Sun","year":"2021","unstructured":"Sun Q, Ye F, Liang H, Liu H, Li C, Lu R, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021;6:212.","journal-title":"Signal Transduct Target Ther"},{"key":"1193_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tips.2020.07.003","volume":"41","author":"A Cuadrado","year":"2020","unstructured":"Cuadrado A, Pajares M, Benito C, Jim\u00e9nez-Villegas J, Escoll M, Fern\u00e1ndez-Gin\u00e9s R, et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020;41:598\u2013610.","journal-title":"Trends Pharmacol Sci"},{"key":"1193_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104537","volume":"169","author":"Y Nio","year":"2019","unstructured":"Nio Y, Sasai M, Akahori Y, Okamura H, Hasegawa H, Oshima M, et al. Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems. Antiviral Res. 2019;169:104537.","journal-title":"Antiviral Res"},{"key":"1193_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091081","author":"A Slama Schwok","year":"2024","unstructured":"Slama Schwok A, Henri J. Long Neuro-COVID-19: current mechanistic views and therapeutic perspectives. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14091081.","journal-title":"Biomolecules"},{"key":"1193_CR57","doi-asserted-by":"publisher","first-page":"1169740","DOI":"10.3389\/fnins.2023.1169740","volume":"17","author":"A Sha","year":"2023","unstructured":"Sha A, Chen H. Infection routes, invasion mechanisms, and drug inhibition pathways of human coronaviruses on the nervous system. Front Neurosci. 2023;17:1169740.","journal-title":"Front Neurosci"},{"key":"1193_CR58","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.01501-15","volume":"89","author":"C Bleau","year":"2015","unstructured":"Bleau C, Filliol A, Samson M, Lamontagne L. Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells. J Virol. 2015;89:9896\u2013908.","journal-title":"J Virol"},{"key":"1193_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12974-022-02514-x","volume":"19","author":"R-C Yang","year":"2022","unstructured":"Yang R-C, Huang K, Zhang H-P, Li L, Zhang Y-F, Tan C, et al. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation. 2022;19:149.","journal-title":"J Neuroinflammation"},{"key":"1193_CR60","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41551-023-01054-w","volume":"8","author":"P Wang","year":"2024","unstructured":"Wang P, Jin L, Zhang M, Wu Y, Duan Z, Guo Y, et al. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system. Nat Biomed Eng. 2024;8:1053\u201368.","journal-title":"Nat Biomed Eng"},{"key":"1193_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105131","volume":"146","author":"TP Buzhdygan","year":"2020","unstructured":"Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020;146:105131.","journal-title":"Neurobiol Dis"},{"key":"1193_CR62","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11481-021-10029-0","volume":"16","author":"BJ DeOre","year":"2021","unstructured":"DeOre BJ, Tran KA, Andrews AM, Ramirez SH, Galie PA. SARS-CoV-2 spike protein disrupts blood-brain barrier integrity via RhoA activation. J Neuroimmune Pharmacol. 2021;16:722\u20138.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1193_CR63","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.stem.2023.09.003","volume":"30","author":"I Chiaradia","year":"2023","unstructured":"Chiaradia I, Imaz-Rosshandler I, Nilges BS, Boulanger J, Pellegrini L, Das R, et al. Tissue morphology influences the temporal program of human brain organoid development. Cell Stem Cell. 2023;30:1351-1367.e10.","journal-title":"Cell Stem Cell"},{"key":"1193_CR64","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41556-024-01393-z","volume":"26","author":"L Coquand","year":"2024","unstructured":"Coquand L, Brunet Avalos C, Mac\u00e9 A-S, Farcy S, Di Cicco A, Lampic M, et al. A cell fate decision map reveals abundant direct neurogenesis bypassing intermediate progenitors in the human developing neocortex. Nat Cell Biol. 2024;26:698\u2013709.","journal-title":"Nat Cell Biol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-025-01193-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:02:22Z","timestamp":1762358542000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-025-01193-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1186\/s12929-025-01193-z","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}